This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
424B3 Table of Contents Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-226364 PROSPECTUS 3,600,000 SHARES
WINNEMUCCA, Nev., July 31, 2018 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount” or “the Company” ) reported today that the Oregon Department of Geology and Mineral Industries (“DOGAMI”) has approved and accepted seven additional baseline environmental reports, bringing the total to 12 reports approved and accepted by the appropriate state agencies. These baseline reports are required for permitting the Company’s 100%-owned Grassy Mountain gold project in eastern Oregon.
WINNEMUCCA, Nev., July 19, 2018 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount”) reported today that the Oregon Department of Geology and Mineral Industries (“DOGAMI”) has approved and accepted a fifth baseline environmental report required for the permitting of Paramount’s proposed Grassy Mountain Gold Project in eastern Oregon.
WINNEMUCCA, Nev., July 16, 2018 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount” or “the Company”) announced today that it has closed the previously announced (press release – June 25, 2018) non-brokered private placement funding of common stock and warrants (the “Transaction”) with accredited investors. The Company issued 2,400,000 units at $1.25 per unit for aggregate proceeds of $3,000,000.
SCHEDULE 13D CUSIP NO: 69924M 109
SCHEDULE 13D CUSIP NO: 69924M 109
Total cash operating costs of $528 per ounce of gold produced (after silver credits) Annual average production of 47,000 ounces of gold and 50,000 ounces of silver for 7.25 years After tax IRR of 28%
pzg-8k_20180625.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
pzg-8k_20180626.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WINNEMUCCA, Nev., June 26, 2018 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount”) announced today that John W. Seaberg has joined its board of directors as Executive Chairman. As a member of Paramount’s executive leadership team Mr. Seaberg will be responsible for Capital Markets.
SA NEM KDX SEA HL KLDX PZG
WINNEMUCCA, Nev., June 25, 2018 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount” or “the Company”) announced today that the Company has received commitments from accredited investors to purchase common stock and warrants in a private transaction (the “Transaction”). Under the terms of the Transaction, Paramount has agreed to sell 2,400,000 units at $1.25 per unit for aggregate proceeds of $3,000,000.
SA SEA PZG
WINNEMUCCA, Nev., June 22, 2018 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount”) will be presenting at the JTVIR Conference in Holmdel, New Jersey on Wednesday, June 27, 2018 at approximately 3:10 PM Eastern Time.
WINNEMUCCA, Nev., June 12, 2018 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount”) reported today that the final monitoring water well drilled adjacent to the mineral reserves at the proposed Grassy Mountain underground mine did not encounter water to a final depth of 950ft., which is considerably below the bottom of the mine plan.
pzg-10q_20180331.htm UNITED STATES
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET